In focus · trending topic

Peripheral T-cell Lymphoma

13 stories · following the connections

Rhizen Pharmaceuticals S.A. receives FDA orphan-drug designation for Tenalisib (RP6530) for treatment of peripheral T-cell lymphoma (PTCL)

By Nasdaq OMXDec 22, 2017, 1:00 PM UTC

Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-539

By Nasdaq OMXApr 5, 2017, 12:01 PM UTC

Kura Oncology Presents Preclinical Data Demonstrating Significant Anti-Tumor Activity of KO-947 and KO-539

By Nasdaq OMXApr 5, 2017, 12:01 PM UTC

Kura Oncology to Report Fourth Quarter and Full Year 2016 Financial Results

By Nasdaq OMXMar 7, 2017, 9:05 PM UTC

Kura Oncology to Participate in Three Upcoming Investor Conferences

By Nasdaq OMXFeb 9, 2017, 9:07 PM UTC

Kura Oncology to Participate in Three Upcoming Investor Conferences

By Nasdaq OMXFeb 9, 2017, 9:07 PM UTC

Kura Oncology to Participate in Three Upcoming Investor Conferences

By Nasdaq OMXFeb 9, 2017, 9:07 PM UTC

Kura Oncology Doses First Patient in Phase 2 Study of Tipifarnib in Chronic Myelomonocytic Leukemia

By Nasdaq OMXJan 17, 2017, 12:30 PM UTC